French Body Favors Pharmacy Substitution For Biosimilars

But Move Is Not Supported By Wider European Off-Patent Industry

 
• By David Wallace
France
Mixed industry views over pharmacy-level substitution for biosimilars in France • Source: Shutterstock

More from Biosimilars

More from Products